logo

For the Inventor, By the Inventor

San Francisco, CA, United States of America

Nektar Therapeutics


USPTO Granted Patents = 415



Trademarks = 3

Forward Citations = 3,954

Loading Chart...
Loading Chart...

255 inventors (with patents filed for the assignee):

goldMedal Antoni Kozlowski (113 out of 140 patents)

silverMedal Samuel P McManus (88 out of 94 patents)

bronzeMedal Jennifer A Riggs-Sauthier (83 out of 98 patents)

4.  Michael David Bentley (79 out of 136 patents)

5.  Xiaoming Shen (52 out of 68 patents)

6.  J Milton Harris (37 out of 89 patents)

7.  Bo-Liang Deng (37 out of 38 patents)

8.  Xuan Zhao (36 out of 101 patents)

9.  Mary J Bossard (36 out of 40 patents)

10.  Sean M Culbertson (32 out of 32 patents)

11.  Wen Zhang (31 out of 32 patents)

12.  Timothy A Riley (29 out of 35 patents)

13.  Zhongxu Ren (28 out of 30 patents)

14.  Lin Cheng (23 out of 64 patents)

15.  Neel Kumar Anand (19 out of 39 patents)


Core Competencies:
Factor VIII Conjugates
Adenosine 2 Receptor Antagonists
IL-2 Moiety Conjugates
TLR Agonist Compounds
Long-Acting IL-15 Agonists
Polymeric Prodrug Conjugates
Immunotherapeutic Treatments
Oligomer-Corticosteroid Conjugates
Kappa Opioid Agonists
Chemically Modified Small Molecules
Protease Inhibitors
Combination-Based Treatment Methods

415 patents:

1. 12325708 - Adenosine 2 receptor antagonists (2025-06-10),
2. 12324828 - Conjugates of a factor VIII moiety having an oxime-containing linkage (2025-06-10),
3. 12247059 - Conjugates of an IL-2 moiety and a polymer (2025-03-11),
4. 12233104 - Combination of an IL-2RBETA-selective agonist and a long-acting IL-15 agonist (2025-02-25),
5. 12214045 - Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods (2025-02-04),
6. 12054553 - Immunotherapeutic tumor treatment method (2024-08-06),
7. 12036283 - Long-acting interleukin-15 receptor agonists and related immunotherapeutic compositions and methods (2024-07-16),
8. 12030940 - Immunotherapeutic tumor treatment method (2024-07-09),
9. 12016952 - Methods of preparing a monodisperse oligo(ethylene glycol) reagent composition (2024-06-25),
10. 11932726 - Method of making releasable polymeric reagents (2024-03-19),
11. 11834553 - Alkoxylation methods (2023-12-05),
12. 11813241 - Multi-arm polymeric prodrug conjugates of taxane-based compounds (2023-11-14),
13. 11744898 - Multi-arm polymer conjugates of TLR agonist compounds and related immunotherapeutic treatment methods (2023-09-05),
14. 11672776 - Multi-arm polymeric alkanoate conjugates (2023-06-13),
15. 11634540 - Polymeric alpha-hydroxy aldehyde and ketone reagents and conjugation method (2023-04-25),
Nektar Therapeutics is a biopharmaceutical company that develops innovative medicines to address unmet medical needs. With a focus on advanced drug delivery technologies, Nektar Therapeutics aims to improve patient outcomes in areas such as cancer, autoimmune diseases, and chronic pain. By leveraging their deep scientific expertise and strategic collaborations, they strive to develop transformative therapies that can make a significant impact on patients' lives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

...
415 Patents

#20 in San Francisco, CA

#245 in California

#1,096 in US

#2,203 in the World

...
San Francisco, CA, United States of America

Nektar Therapeutics

Forward Citations = 3,954

255 inventors:

goldMedal Antoni Kozlowski (113 out of 140 patents)

silverMedal Samuel P McManus (88 out of 94 patents)

bronzeMedal Jennifer A Riggs-Sauthier (83 out of 98 patents)

4.  Michael David Bentley (79 out of 136 patents)

5.  Xiaoming Shen (52 out of 68 patents)

Please report any incorrect information to support@idiyas.com
Loading…